Shellers Honored at Mural Arts Philadelphia’s 2021 Wall Ball
Stephen and Sandy Sheller were honorary attendees at Mural Arts Philadelphia’s 2021 Wall Ball, The Art of Wellbeing. Held virtually June 10, 2021 at 6:00 pm. The Sheller’s have been a long time supporter of Mural Arts’ Philadelphia’s First Same Day Pay Program, “Color Me Back.” The program has been successful addressing the growing problem […]
U.S. Supreme Court Declines J&J Appeal of $70M Risperdal Verdict
Johnson & Johnson is out of options after the U.S. Supreme Court declined to hear the pharmaceutical company’s appeal of a $70 million Risperdal verdict. In the cases of Yount vs. Janssen Pharmaceuticals, the 2019 Superior Court of Pennsylvania ruling stands. Yount’s doctor prescribed Risperdal off-label to address behavioral problems associated with autism when he […]
Trump’s out of office. Allegations of his admission fraud still stand
Stephen Sheller, founder of Sheller P.C., and Eric Orts, Guardsmark Professor at the Wharton School at the University of Pennsylvania, penned a second request to the university’s administration for a formal investigation into allegations former President Trump committed admission fraud. Full letter below published as a guest column in The Daily Pennsylvanian. Stephen Sheller and Eric Orts’ previous letters […]
Stephen Sheller Honored as The Legal’s 2020 Pennsylvania Trailblazer
2020 Pennsylvania Trailblazers brought to you by The Legal Intelligencer Watch: Deadly Drugs – Johnson & Johnson’s Risperdal
PA Supreme Court Upholds $70 Million Risperdal Verdict
The Pennsylvania Supreme Court has denied Johnson & Johnson’s request to overturn the $70 million Risperdal verdict upheld by a Superior court panel of judges last year. The case, A.Y. v. Janssen Pharmaceuticals, will now be remanded back to the PA Court of Common Pleas for a second trial to reconsider punitive damages. “We are […]
Effect of COVID-19 Pandemic on Opioid Crisis and Litigation
As the COVID-19 pandemic continues to plague America, worsening the opioid crisis that has plagued the nation for decades, litigation to recoup the cost of fighting the opioid crisis has stalled. While local and state governments await desperately needs funds to continue to provide services in support of those plagued by addiction to opioids, the […]
$8 Billion Risperdal Verdict Tops Legal News in 2019
April 2020 Update: Stephen Sheller has been recognized by the American Association for Justice with AAJ’s 2019 Top Verdict Award. “Each year, American Association for Justice releases the Top Verdicts Litigation Packet, featuring the opening statements and closing arguments from the previous year’s top cases. Congratulations on the impressive result you secured for your clients […]
Risperdal Case Reinstated After Janssen Appeal Denied
The Pennsylvania Supreme Court declined to hear Janssen Pharmacuetical’s request for an appeal of a lower courts decision to reinstate the lawsuit of a Texas man who took Risperdal as a child. The Pennsylvania Superior Court’s decision to allow Tommy Moroni’s suit against Janssen, a subsidiary of Johnson & Johnson, to go back to trial will stand. July 2019, the Pennsylvania […]
Pharma Execs Admits to Deceptive Marketing of Opioids
In a rare admission to PBS Frontline & the Finical Times, a pharmaceutical executive acknowledged that he knowingly orchestrated an illegal scheme to boost sales of a powerful opiate painkiller believing there would be no consequences for him personally. Alec Burlakoff, Insys’ former head of sales received a 26-month sentence for charges related his role in the pharmaceutical company which […]
Plaintiff’s Counsel Vows to Have $8B Risperdal Verdict Reinstated
Philadelphia Court of Common Pleas Judge Kenneth Powell reduced an October 2019 $8 billion punitive damages verdict against J&J to $6.8 million. A jury had awarded the figure over allegations that J&J’s drug Risperdal caused the plaintiff to grow breasts as a young boy. The $6.8 million reduced verdict is 10 times the jury verdict […]
